Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fertivista Plus is a marketed pharmaceutical formulation developed and distributed by Gynavista, specifically indicated for the management of male infertility. It is a multi-ingredient nutraceutical combination typically composed of antioxidants, amino acids, and micronutrients such as L-carnitine, Coenzyme Q10, Zinc, and Lycopene. The formulation is designed to improve sperm parameters, including count, motility, and morphology, by mitigating oxidative stress in the seminal plasma and enhancing mitochondrial energy production within sperm cells. As a finished pharmaceutical formulation, it is commercially available in the Indian market for oral administration and is positioned within Gynavista's specialized portfolio for reproductive health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fertivista Plus.